{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:37:25Z","timestamp":1777635445312,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U10CA180794"],"award-info":[{"award-number":["U10CA180794"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U10CA180821"],"award-info":[{"award-number":["U10CA180821"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U10CA180868"],"award-info":[{"award-number":["U10CA180868"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U10CA180888"],"award-info":[{"award-number":["U10CA180888"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA189828"],"award-info":[{"award-number":["UG1CA189828"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA233234"],"award-info":[{"award-number":["UG1CA233234"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA233253"],"award-info":[{"award-number":["UG1CA233253"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA233270"],"award-info":[{"award-number":["UG1CA233270"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA233329"],"award-info":[{"award-number":["UG1CA233329"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA233331"],"award-info":[{"award-number":["UG1CA233331"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180820"],"award-info":[{"award-number":["U10CA180820"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006293","name":"American Society of Clinical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006293","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013700","name":"National Comprehensive Cancer Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.prro.2022.01.015","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T23:22:34Z","timestamp":1655335354000},"page":"335-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT\/IGRT"],"prefix":"10.1016","volume":"12","author":[{"given":"Nicholas","family":"Damico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajnan","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Koontz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"McBride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisele","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Bapsi","family":"Chakravarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"O'Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1112-3781","authenticated-orcid":false,"given":"Jennifer","family":"Dorth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2022.01.015_bib0001","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: A Radiation Therapy Oncology Group consensus panel contouring atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0002","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","article-title":"Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer","volume":"83","author":"Ng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0003","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2004.09.060","article-title":"Anal canal carcinoma: Early-stage tumors < or =10 mm (T1 or Tis): Therapeutic options and original pattern of local failure after radiotherapy","volume":"62","author":"Ortholan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0004","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ijrobp.2013.07.035","article-title":"Anal carcinoma: Impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial","volume":"87","author":"Gunderson","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijrobp.2019.10.016","article-title":"Patterns and predictors of relapse following radical chemoradiation therapy delivered using intensity modulated radiation therapy with a simultaneous integrated boost in anal squamous cell carcinoma","volume":"106","author":"Shakir","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0006","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijrobp.2014.06.061","article-title":"Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer","volume":"90","author":"Han","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0007","unstructured":"XXX"},{"key":"10.1016\/j.prro.2022.01.015_bib0008","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0009","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.clon.2014.08.001","article-title":"Anal cancer: Developing an intensity- modulated radiotherapy solution for ACT2 fractionation","volume":"26","author":"Muirhead","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.prro.2022.01.015_bib0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2008.11.007","article-title":"Anatomical bases for the radiological delineation of lymph node areas. Part III: Pelvis and lower limbs","volume":"92","author":"Lengele","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0011","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ijrobp.2005.05.062","article-title":"Mapping pelvic lymph nodes: Guidelines for delineation in intensity-modulated radiotherapy","volume":"63","author":"Taylor","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0012","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ijrobp.2008.09.026","article-title":"Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging","volume":"74","author":"Dinniwell","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0013","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2008.07.023","article-title":"A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imaging","volume":"89","author":"Vilarino-Varela","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0014","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.ijrobp.2005.07.952","article-title":"Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy","volume":"63","author":"Shih","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3, Supplement","key":"10.1016\/j.prro.2022.01.015_bib0015","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1016\/j.ijrobp.2020.07.1813","article-title":"Reduced clinical and planning treatment volumes for anal squamous cell carcinoma yield acceptable outcomes","volume":"108","author":"Grimes","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0016","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13014-020-01567-7","article-title":"Patterns of recurrence in anal cancer: A detailed analysis","volume":"15","author":"Nilsson","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0017","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.radonc.2012.05.011","article-title":"Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patients","volume":"104","author":"Briere","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0018","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ijrobp.2004.11.015","article-title":"Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients","volume":"62","author":"Kim","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0019","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13014-017-0918-5","article-title":"The effect of prone and supine treatment positions for the pre-operative treatment of rectal cancer on organ-at-risk sparing and setup reproducibility using volumetric modulated arc therapy","volume":"12","author":"Kim","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0020","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijrobp.2016.05.025","article-title":"Optimal patient positioning (prone versus supine) for VMAT in gynecologic cancer: A dosimetric study on the effect of different margins","volume":"96","author":"Heijkoop","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0021","series-title":"Radiation Therapy for Gastrointestinal Cancers","author":"Osborne","year":"2017"},{"key":"10.1016\/j.prro.2022.01.015_bib0022","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2016.02.043","article-title":"Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma","volume":"95","author":"Gaffney","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0023","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.radonc.2019.11.016","article-title":"Long-term follow-up experience in anal canal cancer treated with intensity-modulated radiation therapy: Clinical outcomes, patterns of relapse and predictors of failure","volume":"144","author":"de Meric de Bellefon","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0024","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijrobp.2021.08.008","article-title":"Long-term outcomes of NRG Oncology\/RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-c for the reduction of acute morbidity in anal canal cancer","volume":"112","author":"Kachnic","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0025","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jamaoncol.2021.1683","article-title":"Use of total neoadjuvant therapy for locally advanced rectal cancer: Initial results from the pembrolizumab arm of a phase 2 randomized clinical trial","volume":"7","author":"Rahma","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0026","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2010.10.005","article-title":"T1-2 anal carcinoma requires elective inguinal radiation treatment\u2014the results of Trans Tasman Radiation Oncology Group study TROG 99.02","volume":"98","author":"Matthews","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0027","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.ijrobp.2011.02.010","article-title":"Anal canal cancer: Management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study)","volume":"82","author":"Ortholan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0028","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2006.12.052","article-title":"Predictors and patterns of recurrence after definitive chemoradiation for anal cancer","volume":"68","author":"Das","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0029","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2016.07.017","article-title":"International consensus guidelines on clinical target volume delineation in rectal cancer","volume":"120","author":"Valentini","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0030","first-page":"431","article-title":"Detailed and applied anatomy for improved rectal cancer treatment","volume":"32","author":"Nuikolouzakis","year":"2019","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.prro.2022.01.015_bib0031","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3346\/jkms.2008.23.6.999","article-title":"Intra-operative measurement of surgical lengths of the rectum and the peritoneal reflection in Korean","volume":"23","author":"Yun","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.prro.2022.01.015_bib0032","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.radonc.2016.08.011","article-title":"Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT)","volume":"121","author":"Durrant","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0033","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.radonc.2009.04.022","article-title":"Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients","volume":"92","author":"Nijkamp","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0034","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.radonc.2009.08.007","article-title":"Target volume shape variation during irradiation of rectal cancer patients in supine position: Comparison with prone position","volume":"93","author":"Nijkamp","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(17)30071-2","article-title":"Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): A post-hoc analysis of randomised controlled phase 3 trial","volume":"18","author":"Glynne-Jones","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0036","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2010.09.030","article-title":"Dose-painted intensity-modulated radiation therapy for anal cancer: A multi-institutional report of acute toxicity and response to therapy","volume":"82","author":"Kachnic","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0037","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: Survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.prro.2022.01.015_bib0038","article-title":"The pattern and timing of disease recurrence in squamous cancer of the anus: Mature results from the NCRI ACT II trial","volume":"30","author":"Sebag-Montefiore","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0039","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/0284186X.2015.1043396","article-title":"Predictors of acute toxicities during definitive chemoradiation using intensity-modulated radiotherapy for anal squamous cell carcinoma","volume":"55","author":"Julie","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijrobp.2016.10.010","article-title":"Hematologic nadirs during chemoradiation for anal cancer: Temporal characterization and dosimetric predictors","volume":"97","author":"Lee","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0041","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2009.11.010","article-title":"Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy","volume":"79","author":"Rose","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0042","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ijrobp.2011.12.072","article-title":"Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with intensity-modulated radiation therapy for squamous cell carcinoma of the anal canal","volume":"84","author":"Bazan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0043","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ijrobp.2007.08.074","article-title":"Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy","volume":"70","author":"Mell","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0044","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.prro.2017.03.008","article-title":"Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation","volume":"7","author":"Rose","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0045","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijrobp.2015.02.029","article-title":"Dosimetric predictors of radiation-induced vaginal stenosis after pelvic radiation therapy for rectal and anal cancer","volume":"92","author":"Son","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.01.015_bib0046","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.prro.2013.04.002","article-title":"Planning target volume-to-skin proximity for head-and-neck intensity modulated radiation therapy treatment planning","volume":"4","author":"Price","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib0047","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.apradiso.2009.03.008","article-title":"Skin dose measurements using MOSFET and TLD for head and neck patients treated with tomotherapy","volume":"67","author":"Kinhikar","year":"2009","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.prro.2022.01.015_bib0048","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2018.10.021","article-title":"Intensity-modulated radiation therapy of anal squamous cell carcinoma: Relationship between delineation quality and regional recurrence","volume":"131","author":"Rouard","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2022.01.015_bib49","article-title":"EA2182 (DECREASE): Radiation Plan Central Review","author":"Dorth","year":"2020","journal-title":"Paper presented at: ECOG-ACRIN Cancer Research Group, Fall 2020 Virtual Group Meeting, Radiation Oncology Committee Meeting"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850022000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850022000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:24:17Z","timestamp":1761819857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850022000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1879850022000704"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2022.01.015","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT\/IGRT","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2022.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}